SuperworthSkinHealth Systems EPS SKIN
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$4.40
- Latest quarter, Q2 FY26
- −$0.40
- −167% on a year earlier
- Fiscal year 2025
- −$4.00
SkinHealth Systems' earnings per share was −$4.40 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.40, down 167% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$4.00 | n/a |
| FY2024 | −$8.60 | n/a |
| FY2023 | −$15.00 | n/a |
| FY2022 | −$3.40 | n/a |
| FY2021 | −$67.20 | n/a |
| FY2020 | −$12.80 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.40 | −167% | −$4.40 | |
| Q1 FY26 | −$1.00 | n/a | −$3.40 | |
| Q4 FY25 | −$1.20 | n/a | −$4.00 | |
| Q3 FY25 | −$1.80 | n/a | −$4.40 | |
| Q2 FY25 | $0.60 | n/a | −$5.60 | |
| Q1 FY25 | −$1.60 | n/a | −$8.20 | |
| Q4 FY24 | −$1.60 | n/a | −$8.60 | |
| Q3 FY24 | −$3.00 | n/a | −$8.40 | |
| Q2 FY24 | −$2.00 | −433% | −$16.60 | |
| Q1 FY24 | −$2.00 | n/a | −$14.00 | |
| Q4 FY23 | −$1.40 | −240% | −$15.00 | |
| Q3 FY23 | −$11.20 | n/a | −$12.60 |
Against its peers
Companies in Medical - Instruments & Supplies nearest SkinHealth Systems' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| SKINSkinHealth Systems | −$4.40 | |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| NEPHNephros | $0.16 | +33% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| MOVMovado | $1.80 | +137% a year |
| Peer median | $1.27 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on SkinHealth Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.